Innovate UK is launching an Oncology Accelerator as part of its Cancer Therapeutics programme which aims to unleash business-led innovation from the UK’s vibrant research base.
The Accelerator is open to applications from UK organisations developing broad innovations in the field of oncology. Successful applicants will benefit from an intensive five-month programme supporting them to tell a compelling story to potential funders.
Delivered through Lean Life Science (LLS) as part of its Oncology Development Programme 2 (ODP2), the accelerator is focused on de-risking tomorrow’s oncology innovations to maximise commercial and patient impact.
Using LLS’s unique network of relationships from across the R&D ecosystem, OPD2 is designed specifically to support academics and early-stage companies to address the challenges that arise from trying to navigate the fragmented nature of the life science ecosystem. Through a proven structured development programme, ODP2 applies business tools alongside 1-2-1 coaching and mentoring from senior industry and commercial experts-in-residence.
Together with its access to a comprehensive network of partners, LLS provides critical insights and project planning, leading to a validated costed delivery programme, along with the delivery partners needed to accelerate the translational journey of life science innovations into highly-desirable and fundable opportunities.
ODP2 timelines:
- Open for applications until 21 May at 23:00
- ODP2 Programme Information Webinars: 10 May at 13:00 & 17 May at 13:00
- Application Interviews on 1 June
- Successful applicants informed on 2 June
- ODP2 Programme starts on the 6 June and runs for 20 weeks
- Demo Day 19 October 2023
To find out more and/or apply, please click here.
